326 related articles for article (PubMed ID: 16407541)
1. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
Smith PD; Mount MP; Shree R; Callaghan S; Slack RS; Anisman H; Vincent I; Wang X; Mao Z; Park DS
J Neurosci; 2006 Jan; 26(2):440-7. PubMed ID: 16407541
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Mount MP; Zhang Y; Amini M; Callaghan S; Kulczycki J; Mao Z; Slack RS; Anisman H; Park DS
J Biol Chem; 2013 May; 288(20):14362-14371. PubMed ID: 23536182
[TBL] [Abstract][Full Text] [Related]
3. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
5. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
[TBL] [Abstract][Full Text] [Related]
6. Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.
Yao L; Li W; She H; Dou J; Jia L; He Y; Yang Q; Zhu J; Cápiro NL; Walker DI; Pennell KD; Pang Y; Liu Y; Han Y; Mao Z
J Biol Chem; 2012 Oct; 287(41):34246-55. PubMed ID: 22891246
[TBL] [Abstract][Full Text] [Related]
7. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
8. Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson's disease.
Binukumar BK; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
Mol Biol Cell; 2015 Dec; 26(24):4478-91. PubMed ID: 26399293
[TBL] [Abstract][Full Text] [Related]
9. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.
Qu D; Rashidian J; Mount MP; Aleyasin H; Parsanejad M; Lira A; Haque E; Zhang Y; Callaghan S; Daigle M; Rousseaux MW; Slack RS; Albert PR; Vincent I; Woulfe JM; Park DS
Neuron; 2007 Jul; 55(1):37-52. PubMed ID: 17610816
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.
Tang X; Wang X; Gong X; Tong M; Park D; Xia Z; Mao Z
J Neurosci; 2005 May; 25(19):4823-34. PubMed ID: 15888658
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.
Paoletti P; Vila I; Rifé M; Lizcano JM; Alberch J; Ginés S
J Neurosci; 2008 Oct; 28(40):10090-101. PubMed ID: 18829967
[TBL] [Abstract][Full Text] [Related]
12. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Kamei H; Saito T; Ozawa M; Fujita Y; Asada A; Bibb JA; Saido TC; Sorimachi H; Hisanaga S
J Biol Chem; 2007 Jan; 282(3):1687-94. PubMed ID: 17121855
[TBL] [Abstract][Full Text] [Related]
13. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
Crocker SJ; Smith PD; Jackson-Lewis V; Lamba WR; Hayley SP; Grimm E; Callaghan SM; Slack RS; Melloni E; Przedborski S; Robertson GS; Anisman H; Merali Z; Park DS
J Neurosci; 2003 May; 23(10):4081-91. PubMed ID: 12764095
[TBL] [Abstract][Full Text] [Related]
15. CDK5 contributes to neuronal apoptosis via promoting MEF2D phosphorylation in rat model of intracerebral hemorrhage.
Ke K; Shen J; Song Y; Cao M; Lu H; Liu C; Shen J; Li A; Huang J; Ni H; Chen X; Liu Y
J Mol Neurosci; 2015 May; 56(1):48-59. PubMed ID: 25417143
[TBL] [Abstract][Full Text] [Related]
16. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
17. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
[TBL] [Abstract][Full Text] [Related]
18. TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease.
Binukumar BK; Pant HC
Neural Regen Res; 2016 May; 11(5):698-701. PubMed ID: 27335538
[TBL] [Abstract][Full Text] [Related]
19. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
20. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
